205 related articles for article (PubMed ID: 28241741)
1. Differential correlation analysis of glioblastoma reveals immune ceRNA interactions predictive of patient survival.
Chiu YC; Wang LJ; Lu TP; Hsiao TH; Chuang EY; Chen Y
BMC Bioinformatics; 2017 Feb; 18(1):132. PubMed ID: 28241741
[TBL] [Abstract][Full Text] [Related]
2. Parameter optimization for constructing competing endogenous RNA regulatory network in glioblastoma multiforme and other cancers.
Chiu YC; Hsiao TH; Chen Y; Chuang EY
BMC Genomics; 2015; 16 Suppl 4(Suppl 4):S1. PubMed ID: 25917195
[TBL] [Abstract][Full Text] [Related]
3. Identification and functional characterization of lncRNAs acting as ceRNA involved in the malignant progression of glioblastoma multiforme.
Zhang K; Li Q; Kang X; Wang Y; Wang S
Oncol Rep; 2016 Nov; 36(5):2911-2925. PubMed ID: 27600337
[TBL] [Abstract][Full Text] [Related]
4. Estimating survival time of patients with glioblastoma multiforme and characterization of the identified microRNA signatures.
Yerukala Sathipati S; Huang HL; Ho SY
BMC Genomics; 2016 Dec; 17(Suppl 13):1022. PubMed ID: 28155650
[TBL] [Abstract][Full Text] [Related]
5. Interactions of miR-323/miR-326/miR-329 and miR-130a/miR-155/miR-210 as prognostic indicators for clinical outcome of glioblastoma patients.
Qiu S; Lin S; Hu D; Feng Y; Tan Y; Peng Y
J Transl Med; 2013 Jan; 11():10. PubMed ID: 23302469
[TBL] [Abstract][Full Text] [Related]
6. Comprehensive analysis of a long non-coding RNA-mediated competitive endogenous RNA network in glioblastoma multiforme.
Long S; Li G
Exp Ther Med; 2019 Aug; 18(2):1081-1090. PubMed ID: 31316603
[TBL] [Abstract][Full Text] [Related]
7. Risk Score based on microRNA expression signature is independent prognostic classifier of glioblastoma patients.
Sana J; Radova L; Lakomy R; Kren L; Fadrus P; Smrcka M; Besse A; Nekvindova J; Hermanova M; Jancalek R; Svoboda M; Hajduch M; Slampa P; Vyzula R; Slaby O
Carcinogenesis; 2014 Dec; 35(12):2756-62. PubMed ID: 25322872
[TBL] [Abstract][Full Text] [Related]
8. Competing endogenous RNA network analysis identifies critical genes among the different breast cancer subtypes.
Chen J; Xu J; Li Y; Zhang J; Chen H; Lu J; Wang Z; Zhao X; Xu K; Li Y; Li X; Zhang Y
Oncotarget; 2017 Feb; 8(6):10171-10184. PubMed ID: 28052038
[TBL] [Abstract][Full Text] [Related]
9. MicroRNA expression signatures and their correlation with clinicopathological features in glioblastoma multiforme.
Henriksen M; Johnsen KB; Olesen P; Pilgaard L; Duroux M
Neuromolecular Med; 2014 Sep; 16(3):565-77. PubMed ID: 24817689
[TBL] [Abstract][Full Text] [Related]
10. The mRNA related ceRNA-ceRNA landscape and significance across 20 major cancer types.
Xu J; Li Y; Lu J; Pan T; Ding N; Wang Z; Shao T; Zhang J; Wang L; Li X
Nucleic Acids Res; 2015 Sep; 43(17):8169-82. PubMed ID: 26304537
[TBL] [Abstract][Full Text] [Related]
11. A 4-miRNA signature predicts the therapeutic outcome of glioblastoma.
Niyazi M; Pitea A; Mittelbronn M; Steinbach J; Sticht C; Zehentmayr F; Piehlmaier D; Zitzelsberger H; Ganswindt U; Rödel C; Lauber K; Belka C; Unger K
Oncotarget; 2016 Jul; 7(29):45764-45775. PubMed ID: 27302927
[TBL] [Abstract][Full Text] [Related]
12. Identifying survival-associated modules from the dysregulated triplet network in glioblastoma multiforme.
Wang JB; Liu FH; Chen JH; Ge HT; Mu LY; Bao HB; Lin ZG
J Cancer Res Clin Oncol; 2017 Apr; 143(4):661-671. PubMed ID: 28168356
[TBL] [Abstract][Full Text] [Related]
13. Identification of hub genes and regulatory factors of glioblastoma multiforme subgroups by RNA-seq data analysis.
Li Y; Min W; Li M; Han G; Dai D; Zhang L; Chen X; Wang X; Zhang Y; Yue Z; Liu J
Int J Mol Med; 2016 Oct; 38(4):1170-8. PubMed ID: 27572852
[TBL] [Abstract][Full Text] [Related]
14. Cancerin: A computational pipeline to infer cancer-associated ceRNA interaction networks.
Do D; Bozdag S
PLoS Comput Biol; 2018 Jul; 14(7):e1006318. PubMed ID: 30011266
[TBL] [Abstract][Full Text] [Related]
15. Analyzing Differential Regulatory Networks Modulated by Continuous-State Genomic Features in Glioblastoma Multiforme.
Chiu YC; Hsiao TH; Wang LJ; Chen Y; Chuang EY
IEEE/ACM Trans Comput Biol Bioinform; 2018; 15(6):1754-1764. PubMed ID: 28114032
[TBL] [Abstract][Full Text] [Related]
16. Identify signature regulatory network for glioblastoma prognosis by integrative mRNA and miRNA co-expression analysis.
Bing ZT; Yang GH; Xiong J; Guo L; Yang L
IET Syst Biol; 2016 Dec; 10(6):244-251. PubMed ID: 27879479
[TBL] [Abstract][Full Text] [Related]
17. A five-miRNA signature with prognostic and predictive value for MGMT promoter-methylated glioblastoma patients.
Cheng W; Ren X; Cai J; Zhang C; Li M; Wang K; Liu Y; Han S; Wu A
Oncotarget; 2015 Oct; 6(30):29285-95. PubMed ID: 26320189
[TBL] [Abstract][Full Text] [Related]
18. Competing endogenous RNA interplay in cancer: mechanism, methodology, and perspectives.
Cheng DL; Xiang YY; Ji LJ; Lu XJ
Tumour Biol; 2015 Feb; 36(2):479-88. PubMed ID: 25604144
[TBL] [Abstract][Full Text] [Related]
19. A three-microRNA signature identifies two subtypes of glioblastoma patients with different clinical outcomes.
Marziali G; Buccarelli M; Giuliani A; Ilari R; Grande S; Palma A; D'Alessandris QG; Martini M; Biffoni M; Pallini R; Ricci-Vitiani L
Mol Oncol; 2017 Sep; 11(9):1115-1129. PubMed ID: 28248456
[TBL] [Abstract][Full Text] [Related]
20. A 4-miRNAs signature predicts survival in glioblastoma multiforme patients.
Yuan GQ; Wei NL; Mu LY; Wang XQ; Zhang YN; Zhou WN; Pan YW
Cancer Biomark; 2017 Dec; 20(4):443-452. PubMed ID: 28869437
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
